Aib substitution raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2025-09-18 and is reviewed periodically as new material appears.
Lyophilised semaglutide is generally held at -20 °C or below, protected from light and moisture. Reconstituted solutions are typically kept at 2-8 °C and used within a defined window because degradation accumulates over time. Repeated freeze-thaw cycles are discouraged, since each cycle can promote aggregation and reduce monomeric content. Room-temperature stability of the solid has been examined in some studies but remains incompletely characterised for long durations, so cold storage is the conservative default for research material.
Degradation proceeds along several parallel routes. Deamidation of asparagine and glutamine residues generates charged variants that shift retention time in chromatographic analysis. Oxidation targets methionine and can be accelerated by trace metals or dissolved oxygen. Non-covalent aggregation produces dimers, oligomers, and larger species that are difficult to reverse. Isomerisation at aspartate residues is slower but measurable under thermal stress. The distribution among these pathways depends on pH, buffer composition, ionic strength, and the presence of excipients such as sugars or surfactants.
Reverse-phase high-performance liquid chromatography with ultraviolet detection near 214 nm is the standard purity method, reported as area percent. Mass spectrometry, usually with electrospray ionisation, confirms identity and reveals covalent modifications. Size-exclusion chromatography quantifies aggregates and fragments. Peptide mapping after enzymatic digestion localises changes to specific sequence regions. Circular dichroism and infrared spectroscopy report on secondary structure, while light scattering tracks particle formation in liquid formulations. No single technique captures every quality attribute.
Semaglutide is a synthetic peptide analog of glucagon-like peptide-1 (GLP-1), a hormone released from intestinal L-cells after food intake. The compound belongs to the incretin mimetic class and acts at GLP-1 receptors distributed across pancreatic, gastrointestinal, cardiovascular, and central nervous system tissues. Compared with native GLP-1, the molecule carries structural changes that extend its activity from minutes to roughly one week. It is studied for glycemic control in type 2 diabetes and for weight management, and its effects on cardiovascular and other outcomes remain active research areas.
Receptor binding triggers G protein signaling that raises intracellular cyclic AMP in pancreatic beta cells. Insulin release follows in a glucose-dependent manner, so secretion increases when blood glucose is elevated and diminishes when it is not. The same signaling suppresses glucagon release from alpha cells and slows gastric emptying, which blunts the post-meal glucose rise. In the brain, receptor activation in regions such as the arcuate nucleus is associated with reduced appetite and lower energy intake. How much each of these effects contributes to overall weight change is not fully settled.
Two structural features account for the prolonged half-life of semaglutide. A modified amino acid at position 8 resists cleavage by dipeptidyl peptidase-4, the enzyme that rapidly degrades native GLP-1. A fatty diacid side chain binds serum albumin, which limits renal clearance and protects the peptide from enzymatic breakdown. These modifications yield a plasma half-life of approximately one week in humans, allowing once-weekly administration. The relationship between plasma concentration and clinical effect varies between individuals, and sources of that variability are still being characterized.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white lyophilised powder | visual inspection of solid |
| Solubility | Freely soluble in water, pH dependent | buffer choice affects clarity |
| Typical storage | -20 °C, desiccated, protected from light | solution form kept at 2-8 °C |
| Primary purity method | RP-HPLC with UV detection, 214-220 nm | reported as area percent |
| Identity confirmation | LC-ESI-MS, approximately 4114 Da | compared with theoretical mass |
Lyophilized peptide material is typically stored at or below -20 °C, with -80 °C used for longer-term archives. Vials should remain sealed and desiccated because moisture promotes aggregation and hydrolysis. Repeated freeze-thaw cycles are avoided since they can alter peptide conformation and reduce recovery. Once reconstituted, solutions are generally kept at 2-8 °C and used within a defined window. Stability beyond those windows depends on buffer composition and concentration, and exact limits are product-specific rather than universal.
Identity and purity are assessed with reversed-phase high-performance liquid chromatography, which separates the peptide from related impurities by hydrophobicity. Mass spectrometry confirms molecular weight and detects truncation or modification products. Peptide mapping after enzymatic digestion verifies the amino acid sequence. Quantitation is often performed by LC-MS/MS or by immunoassay, and the two approaches can give different values because they measure different things. Method validation parameters such as accuracy, precision, and limit of quantitation are reported alongside results.
Semaglutide is a synthetic peptide analogue of glucagon-like peptide-1, a gut hormone released by intestinal L cells after food intake. The natural hormone acts on pancreatic and central receptors but is degraded within minutes by dipeptidyl peptidase-4 and other peptidases. Semaglutide belongs to the class of long-acting GLP-1 receptor agonists, a group distinguished by structural changes that slow breakdown and extend circulation time. Its development followed earlier short-acting analogues and reflects a general strategy in peptide drug design: preserve receptor activity while blocking proteolytic clearance.
Three structural changes define the molecule. At position 8 an alpha-aminoisobutyric acid residue replaces alanine, which blocks dipeptidyl peptidase-4 cleavage. At position 34 arginine replaces lysine, and at position 26 a lysine carries a C18 fatty diacid attached through a short linker. The fatty chain binds serum albumin, and this albumin association reduces renal filtration and enzymatic attack. The unchanged backbone retains the receptor contacts that produce signalling. The free base has the formula C187H291N45O59 and a molecular weight near 4114 daltons.
Chitosan (griech. χιτών „Unterkleid, Hülle, Panzer“), auch Poliglusam oder Poly-D-Glucosamin oder Polyglucosamin, ist ein natürlich vorkommendes Biopolymer, das sich vom Chitin ableitet und wie dieses ein Polyaminosaccharid ist. Zur Herstellung von Chitosan wird Chitin deacetyliert. Erstmals wurde es 1859 von C. Rouget durch Kochen von Chitin mit Kalilauge gewonnen. Chitosan wird u. a. in der Rettungsmedizin zur Stillung von Blutungen eingesetzt. Viele weitere Anwendungen existieren oder sind in der Entwicklung.
=== Gewinnung === Chitin setzt sich aus β-1,4-glycosidisch verknüpften N-Acetylglucosaminresten (2-Acetamido-2-desoxy-β-D-glucopyranose-Resten) zusammen. Chitosan wird technisch aus Chitin durch Deacetylierung gewonnen, so dass das Molekül schließlich nur noch aus etwa 2000 linear miteinander verbundenen 2-Amino-2-desoxy-β-D-glucopyranose- bzw. Glucosamin-Monomeren besteht. Dies kann durch (heiße) Natronlauge oder enzymatisch erfolgen. Beide Prozesse werden technisch genutzt, mengenmäßig steht die alkalische Prozedur eindeutig im Vordergrund. Der Grad der resultierenden Deacetylierung kann erheblich variieren: Die Deacetylierung kann vollständig oder teilweise erfolgen, woraus eine Verteilung stark deacetylierter neben wenig deacetylierten Bereichen oder eine homogene Deacetylierungsverteilung resultieren kann, was erhebliche Auswirkungen auf die Molekülgestalt hat. Gleichzeitig kann aufgrund dieses chemischen Eingriffes die Kettenlänge des Polymers abnehmen (Depolymerisation), wodurch die Löslichkeit verbessert und die Viskosität verringert wird. Außerdem können bei der Behandlung Fremdatome (z. B. Schwermetalle aus Natronlauge) eingebracht werden. Die Endprodukte können sich daher erheblich in ihren Eigenschaften unterscheiden. Am deutlichsten offenbaren sich diese Unterschiede in der Löslichkeit und Viskosität z. B. einer einprozentigen Chitosanlösung in Essigsäure.
=== Natürliches Vorkommen === Einige Pilze enthalten neben Chitin auch Chitosan in ihrer Zellwand; aus ihnen kann Chitosan direkt gewonnen werden. Alle bekannten Arten wie z. B. Mucor rouxii, Absidia coerulea und Rhizopus oryzae gehören zur Ordnung der Mucorales.
Sources: de.wikipedia.org
== Eigenschaften == Chitosan ist ein farbloser, amorpher, zäher Stoff. Industriell hergestelltes, hochmolekulares Chitosan ist in verdünnten starken Säuren außer Schwefelsäure sowie in organischen Säuren löslich. Die Löslichkeit in Säuren und gleichzeitig schlechte Löslichkeit in neutralem oder alkalischem pH ist einzigartig unter den Biopolymeren und daher charakterisierend. Mit abnehmender molarer Masse ist aber auch Chitosan (oder Oligo-Glucosamin) in Wasser und sogar in Laugen löslich. Auf Grund der durch die Deacetylierung entstandenen freien Aminogruppen ist es in nicht alkalischer Lösung ein Polykation mit einer hohen Ladungsdichte. Es ist ungiftig, antibakteriell, antiviral und antiallergen. Die LD50 von Chitosan liegt bei 16 g/kg Körpermasse.
Sources: de.wikipedia.org
Reverse-phase high-performance liquid chromatography with ultraviolet detection is the usual choice, with results reported as area percent. Complementary methods such as size-exclusion chromatography and mass spectrometry are needed because a single separation cannot resolve every impurity class. Purity figures are therefore method dependent and should always be read alongside the technique used.
Oxidation mainly affects methionine residues and is promoted by dissolved oxygen, trace transition metals, and prolonged exposure to light. Buffer choice and the presence of antioxidants in a formulation can alter the rate appreciably. Because the products differ in mass by only a few units, mass spectrometry is often required to detect them.
Published data on long-term ambient stability are limited, so the question remains open rather than settled. Short excursions during transport are common in practice, and many suppliers use insulated packaging with cold packs. Where stability data are absent, cold-chain handling with temperature logging is the safer approach.
Native GLP-1 is degraded within minutes by dipeptidyl peptidase-4 and cleared quickly. Semaglutide carries a position 8 substitution that blocks that cleavage and a fatty diacid chain that binds albumin. Together these changes extend its circulating half-life to about one week.